The Search for New Drugs | GenomeWeb

The Search for New Drugs

Premium

Drug discovery has never been easy. No one knows how many plants our ancestors tried — or were poisoned by — before figuring out that willow bark could ease a headache or that aloe could soothe a sunburn. Clearly, the drug discovery process has been modernized since then, with advances including high-content screening and the advent of semantic Web tools, but the failure rate remains exceedingly high while the time commitment is also incredibly long. It can take anywhere from three to seven years to go from the discovery to preclinical stages, and the rate of failure is around 90 percent.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.